Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹3,023 Cr₹2,585 Cr₹3,266 Cr₹2,368 Cr₹1,803 Cr

What is the latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS is ₹3,023 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹3,023 Cr
Mar2025₹2,585 Cr
Mar2024₹3,266 Cr
Mar2023₹2,368 Cr
Mar2022₹1,803 Cr

How is Cash Flow from Operating Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹3,023 Cr
16.93
Mar2025 ₹2,585 Cr
-20.85
Mar2024 ₹3,266 Cr
37.92
Mar2023 ₹2,368 Cr
31.34
Mar2022 ₹1,803 Cr -

Compare Cash Flow from Operating Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹180,885.9 Cr -2.4% -5% 33.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,562.0 Cr -3.2% -7.8% 14.1% Stock Analytics
DIVIS LABORATORIES ₹244,572.0 Cr -3.3% -0.2% 63.3% Stock Analytics
CIPLA ₹107,770.0 Cr -4% -5.6% -10.2% Stock Analytics
MANKIND PHARMA ₹102,433.0 Cr 1.7% 4.2% 1.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,829.0 Cr -1.2% 4.1% -4.2% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-2.4%

-5%

33.6%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses